BioCentury
ARTICLE | Product Development

Getting real about COVID-19 data with Amy Abernethy and Mark McClellan

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.

May 8, 2020 11:47 PM UTC
Updated on May 9, 2020 at 12:57 AM UTC

Responding to COVID-19 is forcing regulators, medical product developers and health systems to get real about real-world data and evidence as they reach for every available tool to learn about the disease and speed the development of effective interventions.

Amy Abernethy, FDA’s principal deputy commissioner and acting CIO, and Mark McClellan, director of the Duke-Margolis Center for Health Policy at Duke University, described in interviews for a pair of BioCentury This Week -- Special Report podcasts how the pandemic has accelerated progress on integrating real-world data and evidence into research and practice. ...



Access The Full Article